I am relieved and delighted to learn of the decision of the BC Supreme Court that granted an injunction for SALOME requests for prescription heroin.
I urge Health Canada to expeditiously grant approval for applicants. They have endured enormous political interference from the Minister of Health. They deserve to be approved for needed on going treatment.
This case exemplifies yet another terrible situation where the Conservative government is creating havoc in people’s lives by abandoning evidence-based solutions in favour of politically motivated decisions.
By Annie Bergeron-Oliver and Olesia Plokhii | May 29, 2014 2:26 pm |
In a major blow to the federal government, a B.C. Supreme Court judge has granted an injunction for five heroin addicts to request prescription heroin under Health Canada’s Special Access Program, iPolitics has learned.
In a ruling delivered Thursday, a B.C. judge granted an injunction to all outstanding plaintiff requests, and future SALOME requests for prescription heroin – diacetylmorphine – under the program. The injunction, the judge said in the court document, amounts to a restoration of the “status quo ante”
Providence Health and the Pivot Legal Society launched a lawsuit last November, arguing the Conservatives’ move to restrict access to prescription heroin violates the charter rights of patients who require the drug. The suit was filed on behalf of five plaintiffs in the British Columbia.
The suit followed the introduction of a series of new Health Canada regulations in October that prevent doctors from prescribing heroin, LSD, ecstasy and cocaine under a crucial special access program. The program allows physicians to request unapproved or discontinued drugs for patients with life-threatening conditions. It also prevents those doctors and patients from facing charges under the Criminal Code.
Health Minister Rona Ambrose introduced the new rules one month after Health Canada gave 16 B.C. heroin addicts permission to use diacetylmorphine — prescription heroin — to help transition out of the SALOME medical study being conducted by Providence Health Care and the University of British Columbia.